Washington University School of Medicine

Dr. Jeannie Kelly of Washington University discusses pregnancy care in a post-Roe world.

Wash U researchers say adults who struggle with alcoholism miss an average of 32 workdays annually — twice as many as their counterparts.

Though psilocybin is a Schedule 1 drug, many see opportunities to use it as a treatment for different mental illnesses.

Dementia cases are projected to explode in coming decades, but new research shows lifestyle changes can reduce cases by 40%.

The FDA recently approved a drug the Washington University School of Medicine has been testing for years. We discuss the results of a clinical trial about the effective drug treating lung cancer caused by a genetic mutation.

Area sexual health centers aim to catch up after the pandemic hindered efforts to mitigate and treat sexually transmitted infections.

New research out of Washington University upends the conventional wisdom about immune responses to COVID-19 infections.

While some antibodies remained effective, researchers found it often took more of them to quash the new variants compared to the original virus. The results, along with a growing body of research worldwide, suggest COVID-19 vaccines and treatments may need to be updated in the future.

A study published in the peer-reviewed medical journal Clinical Infectious Diseases finds that in addition to up to half of adults being wrongfully prescribed antibiotics in hospital settings, one in four children given antibiotics in children’s hospitals are prescribed the drugs inappropriately.

A large share of construction workers in Missouri, southern Illinois and Kansas are being diagnosed with muscle and joint injuries each year, according to a large analysis of union health care data from Washington University, and many are prescribed opioid painkillers.